logo
Share SHARE
FONT-SIZE Plus   Neg

CVC, ValueAct Continue To Consider Options For Misys - Update

Funds advised by CVC Capital Partners Limited and ValueAct Capital Master Fund, L.P. continue to consider their options with regard to banking software maker Misys Plc (MSY.L, MUSJF.PK), which earlier in the day announced an agreement to be acquired by an investment vehicle owned by US-based private equity firm Vista Equity Partners for 350 pence per share.

Misys had several suitors, including a joint bid from CVC Capital Partners Ltd. and ValueAct Capital, the largest shareholder in Misys. The company's talks with Switzerland-based rival Temenos Group AG ended last week as the parties couldn't agree on the final terms of a transaction.

The current offer price represents a premium of 7.5 per cent to the closing price of its shares on February 2, the last business day prior to the announcement of discussions between Misys and Temenos regarding a possible combination. The deal is estimated to have a total value of about 1.3 billion pounds ($2.1 billion).

An independent committee of Misys directors has unanimously agreed to recommend that Misys shareholders vote in favor of the deal.

Established in 1979, Misys has presence in Europe, the US, Asia, the Middle East and Africa. It serves over 1,300 customers, including all of the world's top 50 banks. Its solutions enable customers to cut costs, manage risk, meet regulatory requirements and realize competitive advantages.

CVC and ValueAct together are exploring options including a possible recommended joint cash offer for the company, a statement said today. They urged Misys shareholders to take no action at this time.

"However, there can be no certainty that an offer will be made by CVC and ValueAct, nor, if made, that a transaction will result,"the statement added.

MSY.L is currently trading at 355.90 pence, up 26.40 pence or 8.01 percent, on a volume of 16.61 million shares compared to a 3-month average volume of 2.92 million shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT